prophylactic or therapeutic treatment method for aortic fibrosis in an individual, vasoactive intestinal peptide (vip), use of vasoactive intestinal peptide (vip), method for reducing collagen formation or for enhancing collagen degradation in an individual's ortho, and , composition for the prophylactic or therapeutic treatment of aortic fibrosis
The invention relates to compositions comprising vasoactive intestinal peptide (VIP) or fragments thereof, and the use of such compositions in the treatment of aortic fibrosis and other associated conditions.